Evidence map›Paper›PMID 29905381›Full record

ArticleAmerican journal of hematology2018

An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".

Michael B Streiff, Dejan Milentijevic, Keith McCrae, Daniel Yannicelli, Dominique Lejeune, Winnie W Nelson, François Laliberté, Concetta Crivera, Patrick Lefebvre, Jeff Schein and 1 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in American journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Michael B StreiffJohns Hopkins School of Medicine, Baltimore, Maryland.ORCID 0000-0002-6429-3493
Dejan MilentijevicJanssen Scientific Affairs, LLC, Raritan, New Jersey.ORCID 0000-0003-2159-0049
Keith McCraeCleveland Clinic - Taussig Cancer Center, Cleveland, Ohio.
Daniel YannicelliJanssen Pharmaceuticals, Inc, Raritan, New Jersey.
Dominique LejeuneGroupe d'analyse Ltée, Montréal, Québec, Canada.
Winnie W NelsonJanssen Scientific Affairs, LLC, Raritan, New Jersey.
François LalibertéGroupe d'analyse Ltée, Montréal, Québec, Canada.
Concetta CriveraJanssen Scientific Affairs, LLC, Raritan, New Jersey.
Patrick LefebvreGroupe d'analyse Ltée, Montréal, Québec, Canada.
Jeff ScheinJanssen Scientific Affairs, LLC, Raritan, New Jersey.
Alok A KhoranaCleveland Clinic - Taussig Cancer Center, Cleveland, Ohio.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsVenous ThromboembolismAnticoagulantsHeparin, Low-Molecular-WeightHumansAnticoagulantsHeparin, Low-Molecular-Weight

Identifiers

PMID29905381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.